Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−33.91 MXN
−2.25 B MXN
6.42 B MXN
72.66 M
About Beam Therapeutics Inc.
Sector
Industry
CEO
John Evans
Website
Headquarters
Cambridge
Founded
2017
FIGI
BBG0166VGZM1
Beam Therapeutics, Inc. is a biotechnology company, which engages in the establishment of integrated platform for precision genetic medicines. Its pipeline includes BEAM-101, BEAM-302, Engineered Stem Cell Antibody Paired Evasion (ESCAPE), BEAM-301, and BEAM-201. The company was founded by David R. Liu, Feng Zhang, Alexis Komor, Nicole Gaudelli, and J. Keith Joung on January 25, 2017 and is headquartered in Cambridge, MA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of BEAM is 515.00 MXN — it has decreased by −6.36% in the past 24 hours. Watch BEAM THERAPEUTICS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange BEAM THERAPEUTICS INC stocks are traded under the ticker BEAM.
BEAM stock has fallen by −12.71% compared to the previous week, the month change is a 14.75% rise, over the last year BEAM THERAPEUTICS INC has showed a −31.33% decrease.
We've gathered analysts' opinions on BEAM THERAPEUTICS INC future price: according to them, BEAM price has a max estimate of 1,634.86 MXN and a min estimate of 470.02 MXN. Watch BEAM chart and read a more detailed BEAM THERAPEUTICS INC stock forecast: see what analysts think of BEAM THERAPEUTICS INC and suggest that you do with its stocks.
BEAM reached its all-time high on Feb 16, 2023 with the price of 806.00 MXN, and its all-time low was 440.00 MXN and was reached on Jan 18, 2024. View more price dynamics on BEAM chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
BEAM stock is 7.84% volatile and has beta coefficient of 2.36. Track BEAM THERAPEUTICS INC stock price on the chart and check out the list of the most volatile stocks — is BEAM THERAPEUTICS INC there?
Today BEAM THERAPEUTICS INC has the market capitalization of 42.39 B, it has decreased by −7.53% over the last week.
Yes, you can track BEAM THERAPEUTICS INC financials in yearly and quarterly reports right on TradingView.
BEAM THERAPEUTICS INC is going to release the next earnings report on Mar 4, 2025. Keep track of upcoming events with our Earnings Calendar.
BEAM earnings for the last quarter are −23.05 MXN per share, whereas the estimation was −23.31 MXN resulting in a 1.12% surprise. The estimated earnings for the next quarter are −25.62 MXN per share. See more details about BEAM THERAPEUTICS INC earnings.
BEAM THERAPEUTICS INC revenue for the last quarter amounts to 281.15 M MXN, despite the estimated figure of 286.00 M MXN. In the next quarter, revenue is expected to reach 316.90 M MXN.
BEAM net income for the last quarter is −1.90 B MXN, while the quarter before that showed −1.67 B MXN of net income which accounts for −14.05% change. Track more BEAM THERAPEUTICS INC financial stats to get the full picture.
No, BEAM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 23, 2024, the company has 436.00 employees. See our rating of the largest employees — is BEAM THERAPEUTICS INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BEAM THERAPEUTICS INC EBITDA is −3.17 B MXN, and current EBITDA margin is −41.43%. See more stats in BEAM THERAPEUTICS INC financial statements.
Like other stocks, BEAM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BEAM THERAPEUTICS INC stock right from TradingView charts — choose your broker and connect to your account.